HealthAugust 16, 2026
olaparib
oh-LAP-uh-rib
Definition
A PARP inhibitor medication used as a targeted therapy to treat certain types of cancer by preventing cancer cells from repairing their damaged DNA.
Etymology
The name is a portmanteau derived from the chemical class of the drug (poly-ADP ribose polymerase, or PARP, inhibitor) combined with the suffix -ib, which is the standard naming convention for kinase or enzyme inhibitors in pharmacology.
In the news
In the article, olaparib is highlighted as a treatment that, when combined with abiraterone, provides significant clinical benefits for patients with specific genetic mutations in metastatic prostate cancer.
Giuseppe Procopio: New Insights from PROpel
Read the full article ↗Oncodaily